Estrogen plus Progestin and the Risk of Coronary Heart Disease

Manson, JoAnn E., Hsia, Judith, Johnson, Karen C., Rossouw, Jacques E., Assaf, Annlouise R., Lasser, Norman L., Trevisan, Maurizio, Black, Henry R. +7 more·2003·New England Journal of Medicine

Cited by (1,001)

Items 501–600 of 1,001

  1. The Effect of Acupuncture on Postmenopausal Symptoms and Reproductive Hormones: A Sham Controlled Clinical Trial
    Didem Sunay, Muruvvet Ozdiken, Huseyin Arslan, Ali Seven, Yalçın Aral · 2011 · Acupuncture in Medicine
  2. The Role of Estradiol in Traumatic Brain Injury: Mechanism and Treatment Potential
    Erzsébet Kövesdi, Edina Szabó‐Meleg, István M. Ábrahám · 2020 · International Journal of Molecular Sciences
  3. Trust in Scientific Experts on Obesity: Implications for Awareness and Behavior Change
    Sara N. Bleich, Robert J. Blendon, Alyce Sophia Adams · 2007 · Obesity
  4. Lipid Profiles in Women With 45,X vs 46,XX Primary Ovarian Failure
    Margaret M. Cooley · 2003 · JAMA
  5. Cardioprotection by chronic estrogen or superoxide dismutase mimetic treatment in the aged female rat
    Yi Xu, Stephen J. Armstrong, Ivan A. Arenas, Daniel J. Pehowich, Sandra Thomas Davidge · 2004 · American Journal of Physiology-Heart and Circulatory Physiology
  6. Evidence-based guidelines for cardiovascular disease prevention in women
    Livia de Paula Caetano Mosca, L.J Appel, Emelia J. Benjamin · 2004 · ACC Current Journal Review
  7. Emerging Selective Estrogen Receptor Modulators
    Tatjana E. Vogelvang, Marius J. van der Mooren, Velja Mijatovic, Peter Kenemans · 2006 · Drugs
  8. A randomised controlled trial of cognitive-behavioural therapy for women with problematic menopausal hot flushes: MENOS 2 trial protocol
    Beverley Ayers, Eleanor Mann, Myra Sally Hunter · 2011 · BMJ Open
  9. Proteomic risk markers for coronary heart disease and stroke: validation and mediation of randomized trial hormone therapy effects on these diseases
    Ross L. Prentice, Shanshan Zhao, Melissa M. Johnson, Aaron K. Aragaki, Judith A. Hsia, Rebecca D. Jackson, Jacques E. Rossouw, JoAnn E. Manson, Samir Hanash · 2013 · Genome Medicine
  10. A simulation using data from a primary care practice database closely replicated the women's health initiative trial
    Richard L. Tannen, Mark G. Weiner, Dawei Xie, Kurt Thomas Barnhart · 2006 · Journal of Clinical Epidemiology
  11. Gender and estrogen supplementation increases severity of experimental choroidal neovascularization
    Diego G. Espinosa‐Heidmann, Maria E. Marin‐Castaño, Simone Pereira‐Simon, Eleut P. Hernandez, Sharon J. Elliot, Scott W. Cousins · 2004 · Experimental Eye Research
  12. Systemic lupus erythematosus in a multiethnic US cohort (LUMINA): XXI. Disease activity, damage accrual, and vascular events in pre‐ and postmenopausal women
    Mónica Fernández, Jaime Calvo Alén, Graciela S. Alarcón, Jeffrey M. Roseman, Holly M. Bastian, Barri J. Fessler, Gerald McGwin, Luis M. Vilá, Martha L. Sanchez, John D. Reveille et al. · 2005 · Arthritis & Rheumatism
  13. Clinical Management of Takotsubo Cardiomyopathy
    Raymond E. Bietry, Alex Reyentovich, Stuart D. Katz · 2013 · Heart Failure Clinics
  14. Estrogen and salt sensitivity in the female mRen(2).Lewis rat
    Mark C. Chappell, Liliya M. Yamaleyeva, Brian M. Westwood · 2006 · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology
  15. Cardiovascular Risk in Women With Non-Specific Chest Pain (from the Women's Health Initiative Hormone Trials) † ‡
    Jennifer G. Robinson, Robert B. Wallace, Marian C. Limacher, Hong Ren, Barbara B. Cochrane, Sylvia W Wassertheil-Smoller, Judith K. Ockene, Patricia Lanoie Blanchette, Marcia G. Ko · 2008 · The American Journal of Cardiology
  16. Activation of nitric oxide synthesis in human endothelial cells by red clover extracts
    Tommaso Simoncini, Letizia Fornari, Paolo Mannella, Antonella Caruso, Silvia Garibaldi, Chiara Baldacci, Andrea Riccardo Genazzani · 2005 · Menopause The Journal of The North American Menopause Society
  17. Managing the menopause
    Helen Roberts · 2007 · BMJ
  18. Influence of Maternal Dysmetabolic Conditions During Pregnancy on Cardiovascular Disease
    Wulf Palinski, Eric Nicolaides, Antonio Liguori, Claudio Napoli A · 2009 · Journal of Cardiovascular Translational Research
  19. Effects of low and high dose oestradiol and dydrogesterone therapy on insulin and lipoprotein metabolism in healthy postmenopausal women
    Ian F. Godsland, N Manassiev, Carl V. Felton, Anthony J. Proudler, David Crook, Malcolm I. Whitehead, John C. Stevenson · 2004 · Clinical Endocrinology
  20. Gender Differences in Outcome of Conservatively Treated Patients With Asymptomatic High Grade Carotid Stenosis
    Petra Dick, Camillo Sherif, Schila Sabeti, Jasmin Amighi, Erich Minar, Martin Schillinger · 2005 · Stroke
  21. Menopausal Hormone Therapy
    Bhagu R. Bhavnani, Ronald C. Strickler · 2005 · Journal of Obstetrics and Gynaecology Canada
  22. Postmenopausal hormone therapy in clinical perspective
    Howard Neil Hodis, Wendy Jean Mack · 2007 · Menopause The Journal of The North American Menopause Society
  23. Hormone use and patient concerns after the findings of the Women's Health Initiative
    Sharon J. Rolnick, Richard A. Kopher, Terese A. DeFor, Mary E. Kelley · 2005 · Menopause The Journal of The North American Menopause Society
  24. Riluzole improves outcome following ischemia–reperfusion injury to the spinal cord by preventing delayed paraplegia
    Yongchao Wu, Kajana Satkunendrarajah, Michael George Fehlings · 2014 · Neuroscience
  25. Properties of 2 Counterfactual Effect Definitions of a Point Exposure
    W. Dana Flanders, Mitchel Klein · 2007 · Epidemiology
  26. Treating hot flushes in menopausal women with homeopathic treatment–Results of an observational study
    Marie-France Bordet, Aurélie Colas, Philippe Marijnen, J.-F. Masson, M Trichard · 2008 · Homeopathy
  27. Should Progestins Be Blamed for the Failure of Hormone Replacement Therapy to Reduce Cardiovascular Events in Randomized Controlled Trials?
    Kwang Kon Koh, Ichiro Sakuma · 2004 · Arteriosclerosis Thrombosis and Vascular Biology
  28. Ovariectomy enhances SR Ca2+ release and increases Ca2+ spark amplitudes in isolated ventricular myocytes
    Elias Fares, Randi J. Parks, Jennifer K. MacDonald, Jeanne Egar, Susan Ellen Howlett · 2011 · Journal of Molecular and Cellular Cardiology
  29. Impact of hormone replacement on myocardial fatty acid metabolism: Potential role of estrogen
    Pilar Herrero, Pablo F. Soto, Carmen S. Dence, Zulfia Kisrieva-Ware, Deborah A. Delano, Linda R. Peterson, Robert J. Gropler · 2005 · Journal of Nuclear Cardiology
  30. Effect of genetic variations in platelet glycoproteins Ibα and VI on the risk for coronary heart disease events in postmenopausal women taking hormone therapy
    Paul F. Bray, Timothy D. Howard, Eric Vittinghoff, David C. Sane, David M. Herrington · 2006 · Blood
  31. Estrogen actions in the cardiovascular system
    Michael E. Mendelsohn · 2009 · Climacteric
  32. Effects of dehydroepiandrosterone (DHEA) on cardiovascular risk factors in older women with frailty characteristics
    Rebecca S. Boxer, Alison Kleppinger, Jennifer Brindisi, Richard Feinn, J. Burleson, Rose Anne Kenny · 2010 · Age and Ageing
  33. Risk Factors for Age-Related Maculopathy
    Paul Connell, Pearse Andrew Keane, Evelyn C. O’Neill, Rasha Al‐Taie, Edward Loane, Kumari Neelam, John M. Nolan, Stephen Beatty · 2009 · Journal of Ophthalmology
  34. Vascular Inflammation and Atherosclerosis: The Role of Estrogen Receptors
    Eva N. Kassi, Eliana Spilioti, Narjes Nasiri Ansari, Christos Adamopoulos, Paraskevi Moutsatsou, Angeliki Papapanagiotou, Gerasimos Siasos, Dimitris Tousoulis, Athanasios G. Papavassiliou · 2015 · Current Medicinal Chemistry
  35. Challenges and Novel Approaches in the Epidemiological Study of Early Life Influences on Later Disease
    George Davey Smith, Sam D. Leary, Andy Ness, Debbie A. Lawlor · 2009 · Advances in experimental medicine and biology
  36. Sex and Gender Aspects in Vascular Ageing – Focus on Epidemiology, Pathophysiology, and Outcomes
    Ute Seeland, János Nemcsik, Mai Tone Lønnebakken, Karolina R. Kublickiene, Helena Schluchter, Chloe M. Park, Giacomo Pucci, Ioana Monica Mozos, Rosa María Bruno · 2021 · Heart Lung and Circulation
  37. Committee Opinion No. 565
    2013 · Obstetrics and Gynecology
  38. Management of hypertension in women
    Niels Engberding, NANETTE KASS WENGER · 2011 · Hypertension Research
  39. A critique of Women’s Health Initiative Studies (2002-2006)
    Clark · 2007 · Nuclear Receptor Signaling
  40. Association of oestrogen receptor alpha gene polymorphism with the angiographic extent of coronary artery disease
    Arthur Pollak · 2004 · European Heart Journal
  41. Future Directions for Cardiovascular Disease Comparative Effectiveness Research
    Mark Andrew Hlatky, Pamela S. Douglas, Nakela L. Cook, Barbara L. Wells, Emelia J. Benjamin, Kay Dickersin, David Calvin Goff, Alan T. Hirsch, Elaine M. Hylek, Eric David Peterson et al. · 2012 · Journal of the American College of Cardiology
  42. Cardiovascular diseases in American women
    Ying Zhang · 2010 · Nutrition Metabolism and Cardiovascular Diseases
  43. Vascular Disease in Diabetic Women: Why Do They Miss the Female Protection?
    Ana Paula Dantas, Zuleica Bruno Fortes, Maria Helena Catelli de Carvalho · 2012 · Experimental Diabetes Research
  44. Hypertension in women: the role of progesterone and aldosterone
    Ewald Boschitsch, S. Mayerhofer, D Magometschnigg · 2010 · Climacteric
  45. Increasing use of prescription drugs in the United Kingdom
    Frank Zhang, Ronac Mamtani, Frank I. Scott, David Seth Goldberg, Kevin Haynes, James D. Lewis · 2015 · Pharmacoepidemiology and Drug Safety
  46. Menopausal Hormone Therapy Is Associated With Increased Risk of Fecal Incontinence in Women After Menopause
    Kyle D. Staller, Mary K. Townsend, Hamed Khalili, Raaj S. Mehta, Francine Grodstein, William E. Whitehead, Catherine Ann Matthews, Braden Kuo, Andrew Tan Chan · 2017 · Gastroenterology
  47. Menopausal Hormone Therapy and Risks of First Hospitalized Heart Failure and its Subtypes During the Intervention and Extended Postintervention Follow-up of the Women's Health Initiative Randomized Trials
    Longjian Liu, Liviu Klein, Charles B. Eaton, Gurusher Singh Panjrath, Lisa Warsinger Martin, Claudia U. Chae, Philip Greenland, Donald M. Lloyd‐Jones, Jean Wactawski‐Wende, JoAnn E. Manson · 2019 · Journal of Cardiac Failure
  48. Arterial and venous thrombosis: What's the link? A narrative review
    Aurélien Delluc, Karine Lacut, Marc Alan Rodger · 2020 · Thrombosis Research
  49. Relaxin as a natural agent for vascular health
    Danièle Bani · 2008 · Vascular Health and Risk Management
  50. Chronic disease prevention: public health potential and research needs
    Ross L. Prentice · 2004 · Statistics in Medicine
  51. Estrogen Decreases Atherosclerosis in Part by Reducing Hepatic Acyl-CoA:Cholesterol Acyltransferase 2 (ACAT2) in Monkeys
    Kylie Kavanagh, Matthew A. Davis, Li Zhang, Martha D. Wilson, Thomas C. Register, Michael R. Adams, Lawrence L. Rudel, Janice D. Wagner · 2009 · Arteriosclerosis Thrombosis and Vascular Biology
  52. Differential and Opposing Regulation of PAI-1 Promoter Activity by Estrogen Receptor α and Estrogen Receptor β in Endothelial Cells
    Layton Harris Smith, Stephen R. Coats, Hao Qin, Matthew S. Petrie, Joseph W. Covington, Ming Su, Mesut Eren, Douglas E. Vaughan · 2004 · Circulation Research
  53. Heart Failure and its Treatment in Women
    Vera Regitz‐Zagrosek, Elke Lehmkuhl · 2005 · Herz
  54. Menopausal estrogen therapy counteracts normal aging effects on intima thickness, media thickness and intima/media ratio in carotid and femoral arteries
    Tord Naessén, Kenny A. Rodriguez‐Wallberg · 2006 · Atherosclerosis
  55. A Contemporary View of Menopausal Hormone Therapy
    Barbara S. Levy, James A. Simon · 2024 · Obstetrics and Gynecology
  56. Multidisciplinary Strategy for Managing Cardiovascular Risks When Treating Patients with Early Breast Cancer
    Daniel John Lenihan, Francisco J. Esteva · 2008 · The Oncologist
  57. Postmenopausal estrogen and progestin effects on the serum proteome
    Sharon J. Pitteri, Samir Hanash, Aaron K. Aragaki, Lynn M. Amon, Lin Chen, Tina Busald Buson, Sophie Paczesny, Hiroyuki Katayama, Hong Wang, Melissa M. Johnson et al. · 2009 · Genome Medicine
  58. HRT and cardiovascular disease
    John C. Stevenson · 2008 · Best Practice & Research Clinical Obstetrics & Gynaecology
  59. Estrogen potentiates constrictor prostanoid function in female rat aorta by upregulation of cyclooxygenase-2 and thromboxane pathway expression
    Min Li, Lih Kuo, John N. Stallone · 2008 · American Journal of Physiology-Heart and Circulatory Physiology
  60. Postmenopausal hormone therapy before and after the women's health initiative study: what consequences?
    Tomi S. Mikkola, Thomas B. Clarkson, Morris Notelovitz · 2004 · Annals of Medicine
  61. Hormone therapy and Alzheimer?s disease: benefit or harm?
    Victor W. Henderson · 2004 · Expert Opinion on Pharmacotherapy
  62. Safety and benefit considerations for menopausal hormone therapy
    James H. Pickar, David F. Archer, Risa Kagan, JoAnn V. Pinkerton, Hugh Stott Taylor · 2017 · Expert Opinion on Drug Safety
  63. Prevalence and management of hypertension in acute coronary syndrome patients varies by sex: Observations from the Sibrafiban versus aspirin to Yield Maximum Protection from ischemic Heart events postacute cOroNary sYndromes (SYMPHONY) randomized clinical trials
    Camille G. Frazier‐Mills, Svati Hasmukh Shah, Paul W. Armstrong, Manjushri V. Bhapkar, Darren K. McGuire, Zygmunt Sadowski, Arni Kristinsson, Philip E. Aylward, Werner W Klein, W. Douglas Weaver et al. · 2005 · American Heart Journal
  64. Menopausal Hormone Therapy and Cardiovascular Disease Risk: Utility of Biomarkers and Clinical Factors for Risk Stratification
    Shari S. Bassuk, JoAnn E. Manson · 2013 · Clinical Chemistry
  65. Targeted basic research to highlight the role of estrogen and estrogen receptors in the cardiovascular system
    Elke Dworatzek, Shokoufeh Mahmoodzadeh · 2017 · Pharmacological Research
  66. The hypertensive potential of estrogen: An untold story
    Manal Fardoun, Hassan Dehaini, Abdullah A. Shaito, Joelle Edward Mesmar, Ahmed Fawzy EL‐Yazbi, Adnan Badran, Elias Beydoun, Ali Hussein Eid · 2019 · Vascular Pharmacology
  67. Sex hormone ratio changes in men and postmenopausal women with coronary artery disease
    Hong He, Falin Yang, Xianxi Liu, Xianwei Zeng, Qin Hu, Qing xia Zhu, Bing Tu · 2006 · Menopause The Journal of The North American Menopause Society
  68. Hormone replacement therapy and age-related brain shrinkage: regional effects
    Naftali Raz, Karen M. Rodrigue, Kristen M. Kennedy, James D. Acker · 2004 · Neuroreport
  69. Old and new cardiovascular risk factors: from unresolved issues to new opportunities
    Renke Maas, Rainer H. Böger · 2003 · Atherosclerosis Supplements
  70. Ischemic and bleeding outcomes in women treated with bivalirudin during percutaneous coronary intervention: A subgroup analysis of the Randomized Evaluation in PCI Linking Angiomax to Reduced Clinical Events (REPLACE)–2 trial
    Matthews Chacko, Abraham Michael Lincoff, Katherine E. Wolski, David J. Cohen, John A. Bittl, Alexandra J. Lansky, Yoshihiro Tsuchiya, Amadeo Betriu, Michael H. Yen, Derek P. Chew et al. · 2006 · American Heart Journal
  71. Advances in hormone replacement therapy with drospirenone, a unique progestogen with aldosterone receptor antagonism
    Santiago Palacios, Jean‐Michel Foidart, Andrea Ricardo Genazzani · 2006 · Maturitas
  72. Testosterone replacement therapy for late-onset hypogonadism
    Glenn R. Cunningham · 2006 · Nature Clinical Practice Urology
  73. Unique features of dyslipidemia in women across a lifetime and a tailored approach to management
    Neeja Patel, Nikita Mittal, Michael J. Wilkinson, Pam R. Taub · 2024 · American Journal of Preventive Cardiology
  74. European Code against Cancer 4th Edition: Medical exposures, including hormone therapy, and cancer
    Søren Friis, Ausrele Kesminiene, Carolina Espina, Anssi P. Auvinen, Kurt Straíf, Joachim Schüz · 2015 · Cancer Epidemiology
  75. Effect of Hormone Replacement Therapy on Cardiovascular Outcomes: A Meta-Analysis of Randomized Controlled Trials
    Dicheng Yang, Jing Li, Zhongxiang Yuan, Xu Liu · 2013 · PLoS ONE
  76. Osteoporosis treatment and atrial fibrillation
    Weng-Foung Huang, Yi‐Wen Tsai, Yu‐Wen Wen, Fei‐Yuan Hsiao, Ken N. Kuo, Chia-Rung Tsai · 2010 · Menopause The Journal of The North American Menopause Society
  77. Effect of Dietary Fiber Intake on Lipoprotein Cholesterol Levels Independent of Estradiol in Healthy Premenopausal Women
    Sunni L. Mumford, Enrique F. Schisterman, Anna Maria Siega‐Riz, Audrey Jane Gaskins, Jean Wactawski‐Wende, Tyler J. VanderWeele · 2010 · American Journal of Epidemiology
  78. Risk of Inflammatory Bowel Disease with Oral Contraceptives and Menopausal Hormone Therapy: Current Evidence and Future Directions
    Hamed Khalili · 2015 · Drug Safety
  79. Italian association of clinical endocrinologists (AME) position statement: drug therapy of osteoporosis
    Fabio Vescini, Roberto Attanasio, A. Balestrieri, Francisco Alfredo Farias Bandeira, Stefania Bonadonna, Valentina Camozzi, Sara Cassibba, R. Cesareo, Iacopo Chiodini, Cristiano Maria Francucci et al. · 2016 · Journal of Endocrinological Investigation
  80. Drug Therapy for Stable Angina Pectoris
    Talla A. Rousan, Sunil T. Mathew, Udho Thadani · 2017 · Drugs
  81. Estrogen effects on arteries vary with stage of reproductive life and extent of subclinical atherosclerosis progression
    Thomas B. Clarkson · 2018 · Menopause The Journal of The North American Menopause Society
  82. Relationship between Postmenopausal Estrogen Deficiency and Aneurysmal Subarachnoid Hemorrhage
    Sadaharu Tabuchi · 2015 · Behavioural Neurology
  83. Effect of aromatase inhibition on lipids and inflammatory markers of cardiovascular disease in elderly men with low testosterone levels
    Ryan H. Dougherty, Jacqueline L. Rohrer, Douglas Hayden, Stephen D. Rubin, Benjamin Z. Leder · 2005 · Clinical Endocrinology
  84. Have we come full circle – or moved forward? The Women's Health Initiative 10 years on
    Robert D. Langer, JoAnn E. Manson, Matthew Allison · 2012 · Climacteric
  85. Surrogate end-points or primary outcomes in clinical trials in women with polycystic ovary syndrome?
    Richard S. Legro · 2004 · Human Reproduction
  86. Sex matters to the heart: A special issue dedicated to the impact of sex related differences of cardiovascular diseases
    Hester M. den Ruijter, Saskia Haitjema, Folkert Wouter Asselbergs, Gerard Pasterkamp · 2015 · Atherosclerosis
  87. Systemic Effects of Vaginally Administered Estrogen Therapy
    Megan L. Krause, Thomas L. Wheeler, Holly Elizabeth Richter, Thomas E. Snyder · 2010 · Urogynecology
  88. Identification of Menopausal and Reproductive Risk Factors for Microscopic Colitis—Results From the Nurses’ Health Study
    Kristin E. Burke, Ashwin N. Ananthakrishnan, Paul J. Lochhead, Po‐Hong Liu, Ola Olén, Jonas Filip Ludvigsson, James M. Richter, Shelley S. Tworoger, Andrew Tan Chan, Hamed Khalili · 2018 · Gastroenterology
  89. Postmenopausal oral estrogen therapy and blood pressure in normotensive and hypertensive subjects: the Estrogen in the Prevention of Atherosclerosis Trial
    Anne Z. Steiner, Howard Neil Hodis, Rogerio A. Løbo, Donna Shoupe, Min Xiang, Wendy Jean Mack · 2005 · Menopause The Journal of The North American Menopause Society
  90. The forthcoming role of treatment with oestrogens in mental health
    Geyter De · 2007 · Swiss Medical Weekly
  91. Use of Hormone Replacement Therapy by Postmenopausal Women After Publication of the Women's Health Initiative Trial
    Jose Ness, Wilbert S. Aronow, Erin N Newkirk, Deanna L. McDanel · 2005 · The Journals of Gerontology Series A
  92. Age at Menopause, Leukocyte Telomere Length, and Coronary Artery Disease in Postmenopausal Women
    Art Schuermans, Tetsushi Nakao, Md Mesbah Uddin, Whitney Hornsby, Shriienidhie Ganesh, Aladdin H. Shadyab, Simin Liu, Bernhard Haring, CHRISANDRA L. SHUFELT, Margaret A. Taub et al. · 2023 · Circulation Research
  93. 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
    Alberico Luigi Catapano, Ian M Graham, Guy De Backer, Olov Wiklund, M. John Chapman, Heinz Drexel, Arno Wilhelmus Hoes, Catriona Sian Jennings, Ulf Landmesser, Terje Rolf Pedersen et al. · 2016 · Kardiologia Polska
  94. Different mechanisms for benefit and risk of coronary heart disease and stroke in early postmenopausal women
    Rogerio A. Løbo, Tom B. Clarkson · 2010 · Menopause The Journal of The North American Menopause Society
  95. Lasofoxifene, a new selective estrogen receptor modulator for the treatment of osteoporosis and vaginal atrophy
    Luigi Gennari · 2009 · Expert Opinion on Pharmacotherapy
  96. Progestogens regulate endothelial actin cytoskeleton and cell movement via the actin-binding protein moesin
    Xiaodong Fu, Marina Inés Flamini, Angel Matías Sanchez, Lorenzo Goglia, Maria Silvia Giretti, Andrea Riccardo Genazzani, Tommaso Simoncini · 2008 · Molecular Human Reproduction
  97. Postmenopausal Hormone Therapy and Cardiovascular Disease in Perspective
    Howard Neil Hodis, Wendy Jean Mack · 2008 · Clinical Obstetrics & Gynecology
  98. After the women’s health initiative: Decision making and trust of women taking hormone therapy
    Mara A. Schonberg, Roger B. Davis, Christina C. Wee · 2005 · Women s Health Issues
  99. Mortality associated with hormone replacement therapy in younger and older women
    Shelley R. Salpeter · 2006 · Journal of General Internal Medicine
  100. Invited Commentary: Off-Roading With Social Epidemiology—Exploration, Causation, Translation
    M. Maria Glymour, Theresa L. Osypuk, David H. Rehkopf · 2013 · American Journal of Epidemiology